Full Text
Full Text PDF
Abstract
Abstract Liver fibrosis is a wound-healing response generated against an insult to the liver that causes liver injury. It has the potential to progress into cirrhosis, and if not prevented, it may lead to liver cancer and liver failure. The activation of hepatic stellate cells (HSCs) is the central event underlying liver fibrosis. In addition to HSCs, numerous studies have supported the potential contribution of bone marrow-derived cells and myofibroblasts to liver fibrosis. The liver is a heterogeneous organ; thus, molecular and cellular events that underlie liver fibrogenesis are complex. This review aims to focus on major events that occur during liver fibrogenesis. In addition, important antifibrotic therapeutic approaches and experimental liver fibrosis models will be discussed. Cite this article as: Aydın MM, Akçalı KC. Liver fibrosis. Turk J Gastroenterol 2018; 29: 13-20.
Most read articles by the same author(s)
- Murat Kantarcıoğlu, Gülşen Yıldırım, Pınar Akpınar Oktar, Serpil Yanbakan, Zeynep Büşra Özer, Deniz Yurtsever Sarıca, Serpil Taşdelen, Emel Bayrak, Dilara Fatma Akın Balı, Seçkin Öztürk, Kamil Can Akçalı, Üstün Ezer, Ahmet Emin Kürekçi, Coffee-Derived Exosome-Like Nanoparticles: Are They the Secret Heroes? , Turkish Journal of Gastroenterology: Vol. 34 No. 2 (2023): Turkish Journal of Gastroenterology
Article Info
Published In
Journal
Turkish Journal of Gastroenterology
Volume / Issue
Volume 29 · Issue 1
Pages
14-21
History
Published Online
January 15, 2018
Copyright
Copyright (c) 2018 M. Merve Aydın, Kamil Can Akçalı
Affiliations
M. Merve Aydın
Mikrogen Genetic Diagnostic Laboratory, Ankara, Turkey
Kamil Can Akçalı
Department of Biophysics, Ankara University, School of Medicine, Ankara, Turkey
Cite this Article
Aydın, M. M., & Akçalı, K. C. (2018). Liver fibrosis. Turkish Journal of Gastroenterology, 29(1), 14–21. https://doi.org/10.5152/tjg.2018.17330
Outlines